378 related articles for article (PubMed ID: 23946452)
1. Detection of synthetic cannabinoids in oral fluid using ELISA and LC-MS-MS.
Rodrigues WC; Catbagan P; Rana S; Wang G; Moore C
J Anal Toxicol; 2013 Oct; 37(8):526-33. PubMed ID: 23946452
[TBL] [Abstract][Full Text] [Related]
2. Screening of synthetic cannabinoids in preserved oral fluid by UPLC-MS/MS.
Oiestad EL; Johansen U; Christophersen AS; Karinen R
Bioanalysis; 2013 Sep; 5(18):2257-68. PubMed ID: 24053241
[TBL] [Abstract][Full Text] [Related]
3. Quantification of selected synthetic cannabinoids and Δ9-tetrahydrocannabinol in oral fluid by liquid chromatography-tandem mass spectrometry.
de Castro A; Piñeiro B; Lendoiro E; Cruz A; López-Rivadulla M
J Chromatogr A; 2013 Jun; 1295():99-106. PubMed ID: 23680386
[TBL] [Abstract][Full Text] [Related]
4. Analysis of 30 synthetic cannabinoids in oral fluid using liquid chromatography-electrospray ionization tandem mass spectrometry.
Kneisel S; Auwärter V; Kempf J
Drug Test Anal; 2013 Aug; 5(8):657-69. PubMed ID: 23081933
[TBL] [Abstract][Full Text] [Related]
5. Synthetic cannabinoids in oral fluid.
Coulter C; Garnier M; Moore C
J Anal Toxicol; 2011 Sep; 35(7):424-30. PubMed ID: 21871150
[TBL] [Abstract][Full Text] [Related]
6. A rapid quantitative method for the analysis of synthetic cannabinoids by liquid chromatography-tandem mass spectrometry.
Freijo TD; Harris SE; Kala SV
J Anal Toxicol; 2014 Oct; 38(8):466-78. PubMed ID: 25217534
[TBL] [Abstract][Full Text] [Related]
7. Performance characteristics of an ELISA screening assay for urinary synthetic cannabinoids.
Spinelli E; Barnes AJ; Young S; Castaneto MS; Martin TM; Klette KL; Huestis MA
Drug Test Anal; 2015 Jun; 7(6):467-74. PubMed ID: 25167963
[TBL] [Abstract][Full Text] [Related]
8. Determination of 22 synthetic cannabinoids in human hair by liquid chromatography-tandem mass spectrometry.
Hutter M; Kneisel S; Auwärter V; Neukamm MA
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 903():95-101. PubMed ID: 22835826
[TBL] [Abstract][Full Text] [Related]
9. LC/ESI-MS/MS method for quantification of 28 synthetic cannabinoids in neat oral fluid and its application to preliminary studies on their detection windows.
Kneisel S; Speck M; Moosmann B; Corneillie TM; Butlin NG; Auwärter V
Anal Bioanal Chem; 2013 May; 405(14):4691-706. PubMed ID: 23535743
[TBL] [Abstract][Full Text] [Related]
10. A Validated Method for the Detection of Synthetic Cannabinoids in Oral Fluid.
Williams M; Martin J; Galettis P
J Anal Toxicol; 2019 Jan; 43(1):10-17. PubMed ID: 30060217
[TBL] [Abstract][Full Text] [Related]
11. Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction.
Kneisel S; Auwärter V
J Mass Spectrom; 2012 Jul; 47(7):825-35. PubMed ID: 22791249
[TBL] [Abstract][Full Text] [Related]
12. LC-QTOF-MS as a superior strategy to immunoassay for the comprehensive analysis of synthetic cannabinoids in urine.
Kronstrand R; Brinkhagen L; Birath-Karlsson C; Roman M; Josefsson M
Anal Bioanal Chem; 2014 Jun; 406(15):3599-609. PubMed ID: 24424965
[TBL] [Abstract][Full Text] [Related]
13. Ultra high performance liquid chromatography-electrospray ionization-tandem mass spectrometry screening method for direct analysis of designer drugs, "spice" and stimulants in oral fluid.
Strano-Rossi S; Anzillotti L; Castrignanò E; Romolo FS; Chiarotti M
J Chromatogr A; 2012 Oct; 1258():37-42. PubMed ID: 22939380
[TBL] [Abstract][Full Text] [Related]
14. Determination of XLR-11 and its metabolites in hair by liquid chromatography-tandem mass spectrometry.
Park M; Yeon S; Lee J; In S
J Pharm Biomed Anal; 2015 Oct; 114():184-9. PubMed ID: 26070160
[TBL] [Abstract][Full Text] [Related]
15. Validation of a novel immunoassay for the detection of synthetic cannabinoids and metabolites in urine specimens.
Arntson A; Ofsa B; Lancaster D; Simon JR; McMullin M; Logan B
J Anal Toxicol; 2013 Jun; 37(5):284-90. PubMed ID: 23625703
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic properties of the synthetic cannabinoid JWH-018 in oral fluid after inhalation.
Toennes SW; Geraths A; Pogoda W; Paulke A; Wunder C; Theunissen EL; Ramaekers JG
Drug Test Anal; 2018 Apr; 10(4):644-650. PubMed ID: 28967189
[TBL] [Abstract][Full Text] [Related]
17. Detection and quantification of new designer drugs in human blood: Part 1 - Synthetic cannabinoids.
Ammann J; McLaren JM; Gerostamoulos D; Beyer J
J Anal Toxicol; 2012 Jul; 36(6):372-80. PubMed ID: 22593567
[TBL] [Abstract][Full Text] [Related]
18. Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens.
Wohlfarth A; Scheidweiler KB; Castaneto M; Gandhi AS; Desrosiers NA; Klette KL; Martin TM; Huestis MA
Clin Chem Lab Med; 2015 Feb; 53(3):423-34. PubMed ID: 25263309
[TBL] [Abstract][Full Text] [Related]
19. Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in 'herbal mixtures' using LC-MS/MS techniques.
Hutter M; Broecker S; Kneisel S; Auwärter V
J Mass Spectrom; 2012 Jan; 47(1):54-65. PubMed ID: 22282090
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of five naphthoylindole-based synthetic cannabinoids and metabolites and their deposition in human and rat hair.
Kim J; Park Y; Park M; Kim E; Yang W; Baeck S; Lee S; Han S
J Pharm Biomed Anal; 2015 Jan; 102():162-75. PubMed ID: 25282599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
